TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brief Intervention for Suicide Risk Reduction in High Risk Adolescents
Brief Summary: Adolescent suicide is the 2nd leading cause of death in this age group. There are no validated treatments to decrease the risk of adolescent suicidal behavior, and there are especially no interventions to target the highest risk period for adolescent suicide and suicidal behavior, namely during the time of transition from inpatient to outpatient care. This purpose of this project was to develop a novel, brief intervention that can be delivered on an inpatient unit prior to the transition to outpatient care, and augment known factors to protect adolescents from suicidal behavior, and extend the impact of treatment by liaison with the outpatient therapist and the development of a personalized safety plan phone application. This treatment, ASAP, focuses on augmenting adherence to the components of ASAP and outpatient aftercare, development of a personalized Safety Plan, and Affect Protection, through helping the teen and family promote a positive mood, tolerate distress, engage in healthy emotion regulation and access social support.


Options:
A: Arm Label: Iconic Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Emotional regulation | Arm Label: Support therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Emotional regulation | Intervention Type: BEHAVIORAL; Name: Emotional regulation; Assigned to Arm(s): Iconic Therapy, Support therapy
B: Arm Label: ASAP Treatment and Brite; Type: EXPERIMENTAL; Interventions: Behavioral: As Safe As Possible, Behavioral: Brite | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: As Safe As Possible; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Brite; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual
C: Arm Label: Fluoxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluoxetine, Drug: Citalopram | Arm Label: Dialectical behavior therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DBT | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Fluoxetine | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Dialectical behavior therapy | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): Fluoxetine
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Smartphone Assisted PST; Type: EXPERIMENTAL; Interventions: Other: Smartphone Assisted PST | Intervention Type: OTHER; Name: Smartphone Assisted PST; Assigned to Arm(s): Smartphone Assisted PST

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brief Intervention for Suicide Risk Reduction in High Risk Adolescents
Brief Summary: Adolescent suicide is the 2nd leading cause of death in this age group. There are no validated treatments to decrease the risk of adolescent suicidal behavior, and there are especially no interventions to target the highest risk period for adolescent suicide and suicidal behavior, namely during the time of transition from inpatient to outpatient care. This purpose of this project was to develop a novel, brief intervention that can be delivered on an inpatient unit prior to the transition to outpatient care, and augment known factors to protect adolescents from suicidal behavior, and extend the impact of treatment by liaison with the outpatient therapist and the development of a personalized safety plan phone application. This treatment, ASAP, focuses on augmenting adherence to the components of ASAP and outpatient aftercare, development of a personalized Safety Plan, and Affect Protection, through helping the teen and family promote a positive mood, tolerate distress, engage in healthy emotion regulation and access social support.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: APSOM vs Control | Arm Label: APSOM; Type: OTHER; Interventions: Other: APSOM vs Control | Intervention Type: OTHER; Name: APSOM vs Control; Assigned to Arm(s): APSOM, Control
B: Arm Label: ASAP Treatment and Brite; Type: EXPERIMENTAL; Interventions: Behavioral: As Safe As Possible, Behavioral: Brite | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: As Safe As Possible; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Brite; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual
C: Arm Label: Adjunctive Internet-delivered ERITA; Type: EXPERIMENTAL; Interventions: Behavioral: Emotion regulation individual therapy | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Emotion regulation individual therapy; Assigned to Arm(s): Adjunctive Internet-delivered ERITA | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Treatment as usual
D: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brief Intervention for Suicide Risk Reduction in High Risk Adolescents
Brief Summary: Adolescent suicide is the 2nd leading cause of death in this age group. There are no validated treatments to decrease the risk of adolescent suicidal behavior, and there are especially no interventions to target the highest risk period for adolescent suicide and suicidal behavior, namely during the time of transition from inpatient to outpatient care. This purpose of this project was to develop a novel, brief intervention that can be delivered on an inpatient unit prior to the transition to outpatient care, and augment known factors to protect adolescents from suicidal behavior, and extend the impact of treatment by liaison with the outpatient therapist and the development of a personalized safety plan phone application. This treatment, ASAP, focuses on augmenting adherence to the components of ASAP and outpatient aftercare, development of a personalized Safety Plan, and Affect Protection, through helping the teen and family promote a positive mood, tolerate distress, engage in healthy emotion regulation and access social support.


Options:
A: Arm Label: Dialectical Behavior Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behaviour Therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy; Assigned to Arm(s): Dialectical Behavior Therapy
B: Arm Label: meditation; Type: EXPERIMENTAL; Interventions: Behavioral: Central Meditation and Imagery Therapy | Arm Label: wait list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Central Meditation and Imagery Therapy; Assigned to Arm(s): meditation
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: quetiapine extended-release | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: quetiapine extended-release | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: quetiapine extended-release; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3
D: Arm Label: ASAP Treatment and Brite; Type: EXPERIMENTAL; Interventions: Behavioral: As Safe As Possible, Behavioral: Brite | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: As Safe As Possible; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Brite; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
Brief Summary: This study is designed to test a standard mailed intervention (SI) versus a novel decision support and navigation intervention (DSNI). Working with patients and stakeholders, this randomized trial will include 400 Hispanic men and women who are 50 to 75 years of age, patients in community based primary care practices, and are eligible for CRC screening. We will consent, survey, and randomize participants either to the SI Group (n=200) or the DSNI Group (n=200). Study specific aims are to: (1) Assess intervention (DSNI versus SI) impact on overall CRC screening adherence; (2)Assess intervention (DNSI versus SI) impact on CRC screening decision stage; (3) Assess intervention (DNSI versus SI) impact on test-specific CRC screening adherence; and (4) Assess intervention (DNSI versus SI) impact on CRC and knowledge and perceptions.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Care for Korean Americans | Intervention Type: BEHAVIORAL; Name: Diabetes Care for Korean Americans; Assigned to Arm(s): 1
B: Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard | Arm Label: Decision Support & Navigation; Type: EXPERIMENTAL; Interventions: Behavioral: Decision Support & Navigation | Intervention Type: BEHAVIORAL; Name: Decision Support & Navigation; Assigned to Arm(s): Decision Support & Navigation | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard
C: Intervention Type: BEHAVIORAL; Name: Self-Help Intervention Program-High Blood Pressure; Assigned to Arm(s): N/A
D: Arm Label: SCT-based behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SCT-based behavioral intervention | Arm Label: Attention control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: SCT-based behavioral intervention; Assigned to Arm(s): SCT-based behavioral intervention | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
Brief Summary: This study is designed to test a standard mailed intervention (SI) versus a novel decision support and navigation intervention (DSNI). Working with patients and stakeholders, this randomized trial will include 400 Hispanic men and women who are 50 to 75 years of age, patients in community based primary care practices, and are eligible for CRC screening. We will consent, survey, and randomize participants either to the SI Group (n=200) or the DSNI Group (n=200). Study specific aims are to: (1) Assess intervention (DSNI versus SI) impact on overall CRC screening adherence; (2)Assess intervention (DNSI versus SI) impact on CRC screening decision stage; (3) Assess intervention (DNSI versus SI) impact on test-specific CRC screening adherence; and (4) Assess intervention (DNSI versus SI) impact on CRC and knowledge and perceptions.


Options:
A: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Self Study; Type: EXPERIMENTAL; Interventions: Behavioral: Education + Problem-Solving Training Self-Study | Arm Label: Group Problem-Solving Training; Type: EXPERIMENTAL; Interventions: Behavioral: Education + Group Problem-Solving Training | Arm Label: Individual Problem-Solving Training; Type: EXPERIMENTAL; Interventions: Behavioral: Education + Individual Problem-Solving Training | Intervention Type: BEHAVIORAL; Name: Education + Problem-Solving Training Self-Study; Assigned to Arm(s): Self Study | Intervention Type: BEHAVIORAL; Name: Education + Group Problem-Solving Training; Assigned to Arm(s): Group Problem-Solving Training | Intervention Type: BEHAVIORAL; Name: Education + Individual Problem-Solving Training; Assigned to Arm(s): Individual Problem-Solving Training | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: no intervention control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: experimental intervention group; Type: EXPERIMENTAL; Interventions: Other: video decision aid | Intervention Type: OTHER; Name: video decision aid; Assigned to Arm(s): experimental intervention group
C: Arm Label: communication skills training; Type: EXPERIMENTAL; Interventions: Behavioral: patient training in shared decision making | Arm Label: cognitive training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: cognitive training | Intervention Type: BEHAVIORAL; Name: patient training in shared decision making; Assigned to Arm(s): communication skills training | Intervention Type: BEHAVIORAL; Name: cognitive training; Assigned to Arm(s): cognitive training
D: Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard | Arm Label: Decision Support & Navigation; Type: EXPERIMENTAL; Interventions: Behavioral: Decision Support & Navigation | Intervention Type: BEHAVIORAL; Name: Decision Support & Navigation; Assigned to Arm(s): Decision Support & Navigation | Intervention Type: BEHAVIORAL; Name: Standard; Assigned to Arm(s): Standard

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Safety and Tolerability of an Aerobic and Resistance Exercise Program With Cognitive Training Post-stroke
Brief Summary: It is estimated that 2 out of 3 patients with a stroke have some problems with their memory, difficulties performing certain tasks, making decisions and learning new things. In addition, many stroke patients do not get regular exercise and are often sedentary. Both physical and cognitive exercise have the potential to improve quality of life, cognition, and overall health, but the safety and tolerability of such interventions is not clear in stroke patients. The investigators will examine these outcomes by allocating stroke survivor participants to one of two groups: a combined exercise and cognitive training program and a sham control group.


Options:
A: Arm Label: Robotic Treatment plus VR; Type: EXPERIMENTAL; Interventions: Device: Robotic Treatment plus VR | Arm Label: Robotic treatment without VR; Type: ACTIVE_COMPARATOR; Interventions: Device: Robotic Treatment plus VR | Arm Label: Conventional treatment; Type: ACTIVE_COMPARATOR; Interventions: Device: Robotic Treatment plus VR | Intervention Type: DEVICE; Name: Robotic Treatment plus VR; Assigned to Arm(s): Conventional treatment, Robotic Treatment plus VR, Robotic treatment without VR
B: Arm Label: Conventional rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional rehabilitation. | Arm Label: Novel rehabilitation approach; Type: EXPERIMENTAL; Interventions: Behavioral: Novel rehabilitation approach | Intervention Type: BEHAVIORAL; Name: Conventional rehabilitation.; Assigned to Arm(s): Conventional rehabilitation | Intervention Type: BEHAVIORAL; Name: Novel rehabilitation approach; Assigned to Arm(s): Novel rehabilitation approach
C: Arm Label: Cognitive training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive training | Arm Label: Aerobic exercise training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic exercise training | Arm Label: Sequential training group; Type: EXPERIMENTAL; Interventions: Behavioral: Sequential combination of aerobic exercise and cognitive training | Intervention Type: BEHAVIORAL; Name: Cognitive training; Assigned to Arm(s): Cognitive training group | Intervention Type: BEHAVIORAL; Name: Aerobic exercise training; Assigned to Arm(s): Aerobic exercise training group | Intervention Type: BEHAVIORAL; Name: Sequential combination of aerobic exercise and cognitive training; Assigned to Arm(s): Sequential training group
D: Arm Label: CARET + CTI; Type: EXPERIMENTAL; Interventions: Behavioral: CARET, Behavioral: CTI | Arm Label: Sham CARET + Sham CTI; Type: SHAM_COMPARATOR; Interventions: Behavioral: Sham CARET, Behavioral: Sham CTI | Intervention Type: BEHAVIORAL; Name: CARET; Assigned to Arm(s): CARET + CTI | Intervention Type: BEHAVIORAL; Name: CTI; Assigned to Arm(s): CARET + CTI | Intervention Type: BEHAVIORAL; Name: Sham CARET; Assigned to Arm(s): Sham CARET + Sham CTI | Intervention Type: BEHAVIORAL; Name: Sham CTI; Assigned to Arm(s): Sham CARET + Sham CTI

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor (NOFOX): a Randomized Control Trial
Brief Summary: The overall purpose of this study is to determine if adding oxytocin to a Foley catheter for induction of labor will increase the rate of delivery within 24 hours stratified by parity.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Induction of labor with foley balloon - 60cc of saline | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Induction of labor with foley balloon with 30cc | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon - 60cc of saline; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Induction of labor with foley balloon with 30cc; Assigned to Arm(s): 2
B: Arm Label: sequential; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Arm Label: Concurrent; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Concurrent, sequential | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Concurrent, sequential
C: Arm Label: Nulliparous - Foley only; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcervical Foley catheter | Arm Label: Nulliparous - Foley and oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin, Device: Transcervical Foley catheter | Arm Label: Multi(primi)parous - Foley only; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcervical Foley catheter | Arm Label: Multi(primi)parous - Foley and oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin, Device: Transcervical Foley catheter | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Multi(primi)parous - Foley and oxytocin, Nulliparous - Foley and oxytocin | Intervention Type: DEVICE; Name: Transcervical Foley catheter; Assigned to Arm(s): Multi(primi)parous - Foley and oxytocin, Multi(primi)parous - Foley only, Nulliparous - Foley and oxytocin, Nulliparous - Foley only
D: Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Arm Label: Foley Catheter and Oxytocin; Type: EXPERIMENTAL; Interventions: Device: Foley Catheter, Drug: Oxytocin | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter and Oxytocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Foley Catheter and Oxytocin, Oxytocin

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor (NOFOX): a Randomized Control Trial
Brief Summary: The overall purpose of this study is to determine if adding oxytocin to a Foley catheter for induction of labor will increase the rate of delivery within 24 hours stratified by parity.


Options:
A: Arm Label: Nulliparous - Foley only; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcervical Foley catheter | Arm Label: Nulliparous - Foley and oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin, Device: Transcervical Foley catheter | Arm Label: Multi(primi)parous - Foley only; Type: ACTIVE_COMPARATOR; Interventions: Device: Transcervical Foley catheter | Arm Label: Multi(primi)parous - Foley and oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin, Device: Transcervical Foley catheter | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Multi(primi)parous - Foley and oxytocin, Nulliparous - Foley and oxytocin | Intervention Type: DEVICE; Name: Transcervical Foley catheter; Assigned to Arm(s): Multi(primi)parous - Foley and oxytocin, Multi(primi)parous - Foley only, Nulliparous - Foley and oxytocin, Nulliparous - Foley only
B: Arm Label: Foley Bulb plus Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Foley bulb | Arm Label: Misoprostol; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): Foley Bulb plus Misoprostol
C: Arm Label: sequential; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Arm Label: Concurrent; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Concurrent, sequential | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Concurrent, sequential
D: Intervention Type: DRUG; Name: low dose oxytocin; Assigned to Arm(s): N/A

Answer: A